Evaluation of the ability of continuous palonosetron infusion, using a patient-controlled analgesia device, to reduce postoperative nausea and vomiting.

12.1%, P = 0.800) time intervals, the difference in PONV incidence between the continuous infusion group and the single injection group was marginally significant at the 6-24 h time interval (13.6 vs. 27.3%, P = 0.084) ( Fig. 1 ).

also in 26,082 other papers